Involvement of protease-activated receptor 2 in nociceptive behavior in a rat model of bone cancer

Journal of Molecular Neuroscience

Volumn 52, Issue 4, 2014, Pages 566-576

  Bao, Yanju ^a   Hua, Baojin ^a   Hou, Wei ^a   Shi, Zhan ^a   Li, Weidong ^a   Li, Conghuang ^a   Chen, Cihui ^b   Liu, Rui ^a   Qin, Yinggang ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^b ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Bone cancer pain; Mechanical allodynia; PAR2; Rat; Spontaneous nocifensive behavior; Thermal hyperalgesia

Indexed keywords

PROTEINASE ACTIVATED RECEPTOR 2;

ALLODYNIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE ATROPHY; BONE CANCER; BONE RADIOGRAPHY; CANCER PAIN; CELL SIZE; CONTROLLED STUDY; DORSAL ROOT; FEMALE; HEAT SENSITIVITY; HYPERALGESIA; INFLAMMATORY INFILTRATE; NOCICEPTION; NONHUMAN; PROTEIN EXPRESSION; RAT; RAT MODEL; SPINAL CORD NERVE CELL; SPINAL GANGLION; TIBIA; ANIMAL; BONE TUMOR; CARCINOMA; COMPLICATION; DISEASE MODEL; METABOLISM; OSTEOLYSIS; PAIN; PATHOLOGY; PHYSIOLOGY; RADIOGRAPHY; SENSORY NERVE CELL; WISTAR RAT;

ANIMALS; BONE NEOPLASMS; CARCINOMA 256, WALKER; DISEASE MODELS, ANIMAL; FEMALE; GANGLIA, SPINAL; HYPERALGESIA; NOCICEPTION; OSTEOLYSIS; PAIN; RATS; RATS, WISTAR; RECEPTOR, PAR-2; SENSORY RECEPTOR CELLS; TIBIA;

EID: 84899083039     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-013-0112-7     Document Type: Article

References (40)

1. Al-Ani B, Saifeddine M, Wijesuriya SJ, Hollenberg MD (2002) Modified proteinase-activated receptor-1 and -2 derived peptides inhibit proteinase-activated receptor-2 activation by trypsin. J Pharmacol Exp Ther 300(2):702-708
2. Alessandri-Haber N, Dina OA, Joseph EK, Reichling DB, Levine JD (2008) Interaction of transient receptor potential vanilloid 4, integrin, and SRC tyrosine kinase in mechanical hyperalgesia. J Neurosci 28(5):1046-1057 (Pubitemid 351186354)
3. Alier KA, Endicott JA, Stemkowski PL, Cenac N, Cellars L, Chapman K, Andrade-Gordon P, Vergnolle N, Smith PA (2008) Intrathecal administration of proteinase-activated receptor-2 agonists produces hyperalgesia by exciting the cell bodies of primary sensory neurons. J Pharmacol Exp Ther 324(1):224-233 (Pubitemid 350294180)
4. Amadesi S, Cottrell GS, Divino L, Chapman K, Grady EF, Bautista F, Karanjia R, Barajas-Lopez C, Vanner S, Vergnolle N, Bunnett NW (2006) Protease-activated receptor 2 sensitizes TRPV1 by protein kinase Cepsilon- and A-dependent mechanisms in rats and mice. J Physiol 575(Pt 2):555-571 (Pubitemid 44270181)
5. Andoh T, Takayama Y, Yamakoshi T, Lee JB, Sano A, Shimizu T, Kuraishi Y (2012) Involvement of serine protease and proteinase-activated receptor 2 in dermatophyte-associated itch in mice. J Pharmacol Exp Ther 343(1):91-96
6. Barbara G, Wang B, Stanghellini V, de Giorgio R, Cremon C, Di Nardo G, Trevisani M, Campi B, Geppetti P, Tonini M, Bunnett NW, Grundy D, Corinaldesi R (2007) Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 132(1):26-37 (Pubitemid 46108761)
7. Bruera E, Kim HN (2003) Cancer pain. JAMA 290(18):2476-2479 (Pubitemid 37430548)
8. Cenac N, Andrews CN, Holzhausen M, Chapman K, Cottrell G, Andrade-Gordon P, Steinhoff M, Barbara G, Beck P, Bunnett NW, Sharkey KA, Ferraz JG, Shaffer E, Vergnolle N (2007) Role for protease activity in visceral pain in irritable bowel syndrome. J Clin Invest 117(3):636-647 (Pubitemid 46348522)
9. Chen Y, Yang C, Wang ZJ (2011) Proteinase-activated receptor 2 sensitizes transient receptor potential vanilloid 1, transient receptor potential vanilloid 4, and transient receptor potential ankyrin 1 in paclitaxel-induced neuropathic pain. Neuroscience 193:440-451
10. Costa R, Marotta DM, Manjavachi MN, Fernandes ES, Lima-Garcia JF, Paszcuk AF, Quintao NL, Juliano L, Brain SD, Calixto JB (2008) Evidence for the role of neurogenic inflammation components in trypsin-elicited scratching behaviour in mice. Br J Pharmacol 154(5):1094-1103 (Pubitemid 351915068)
11. Cottrell GS, Amadesi S, Schmidlin F, Bunnett N (2003) Protease-activated receptor 2: activation, signalling and function. Biochem Soc Trans 31(Pt 6):1191-1197 (Pubitemid 38030937)
12. Ghilardi JR, Rohrich H, Lindsay TH, Sevcik MA, Schwei MJ, Kubota K, Halvorson KG, Poblete J, Chaplan SR, Dubin AE, Carruthers NI, Swanson D, Kuskowski M, Flores CM, Julius D, Mantyh PW (2005a) Selective blockade of the capsaicin receptor TRPV1 attenuates bone cancer pain. J Neurosci 25(12):3126-3131 (Pubitemid 40463547)
13. Ghilardi JR, Rohrich H, Lindsay TH, Sevcik MA, Schwei MJ, Kubota K, Halvorson KG, Poblete J, Chaplan SR, Dubin AE, Carruthers NI, Swanson D, Kuskowski M, Flores CM, Julius D, Mantyh PW (2005b) Selective blockade of the capsaicin receptor TRPV1 attenuates bone cancer pain. J Neurosci 25(12):3126-3131 (Pubitemid 40463547)
14. Goblirsch MJ, Zwolak P, Clohisy DR (2005) Advances in understanding bone cancer pain. J Cell Biochem 96(4):682-688 (Pubitemid 41567539)
15. Grant AD, Cottrell GS, Amadesi S, Trevisani M, Nicoletti P, Materazzi S, Altier C, Cenac N, Zamponi GW, Bautista-Cruz F, Lopez CB, Joseph EK, Levine JD, Liedtke W, Vanner S, Vergnolle N, Geppetti P, Bunnett NW(2007) Protease-activated receptor 2 sensitizes the transient receptor potential vanilloid 4 ion channel to cause mechanical hyperalgesia in mice. J Physiol 578(Pt 3):715-733 (Pubitemid 46165505)
16. Honore P, Wismer CT, Mikusa J, Zhu CZ, Zhong C, Gauvin DM, Gomtsyan A, El KR, Lee CH, Marsh K, Sullivan JP, Faltynek CR, Jarvis MF (2005) A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological pain associated with inflammation and tissue injury in rats. J Pharmacol Exp Ther 314(1):410-421 (Pubitemid 41058279)
17. Hoogerwerf WA, Zou L, Shenoy M, Sun D, Micci MA, Lee-Hellmich H, Xiao SY, Winston JH, Pasricha PJ (2001) The proteinase-activated receptor 2 is involved in nociception. J Neurosci 21(22):9036-9042 (Pubitemid 33054865)
18. Lam DK, Schmidt BL (2010) Serine proteases and protease-activated receptor 2-dependent allodynia: a novel cancer pain pathway. Pain 149(2):263-272
19. Lam DK, Dang D, Zhang J, Dolan JC, Schmidt BL (2012) Novel animal models of acute and chronic cancer pain: a pivotal role for PAR2. J Neurosci 32(41):14178-14183
20. Lawson SN (2002a) Phenotype and function of somatic primary afferent nociceptive neurones with C-, Adelta- or Aalpha/beta-fibres. Exp Physiol 87(2):239-244
21. Lawson SN (2002b) Phenotype and function of somatic primary afferent nociceptive neurones with C-, Adelta- or Aalpha/beta-fibres. Exp Physiol 87(2):239-244
22. Liu S, Liu YP, Yue DM, Liu GJ. 2013. Protease-activated receptor 2 in dorsal root ganglion contributes to peripheral sensitization of bone cancer pain. Eur J Pain.
23. Mach DB, Rogers SD, Sabino MC, Luger NM, Schwei MJ, Pomonis JD, Keyser CP, Clohisy DR, Adams DJ, O'Leary P, Mantyh PW (2002) Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur. Neuroscience 113(1):155-166 (Pubitemid 34786021)
24. Mantyh PW, Clohisy DR, Koltzenburg M, Hunt SP (2002) Molecular mechanisms of cancer pain. Nat Rev Cancer 2(3):201-209 (Pubitemid 37328789)
25. Mao-Ying QL, Zhao J, Dong ZQ, Wang J, Yu J, Yan MF, Zhang YQ, Wu GC, Wang YQ (2006) A rat model of bone cancer pain induced by intra-tibia inoculation of Walker 256 mammary gland carcinoma cells. Biochem Biophys Res Commun 345(4):1292-1298 (Pubitemid 43817875)
26. Medhurst SJ, Walker K, Bowes M, Kidd BL, Glatt M, Muller M, Hattenberger M, Vaxelaire J, O'Reilly T, Wotherspoon G, Winter J, Green J, Urban L (2002) A rat model of bone cancer pain. Pain 96(1-2):129-140 (Pubitemid 34270635)
27. Menendez L, Lastra A, Fresno MF, Llames S, Meana A, Hidalgo A, Baamonde A (2003) Initial thermal heat hypoalgesia and delayed hyperalgesia in a murine model of bone cancer pain. Brain Res 969(1-2):102-109 (Pubitemid 36369617)
28. Mercadante S (1997) Malignant bone pain: pathophysiology and treatment. Pain 69(1-2):1-18
29. Noorbakhsh F, Tsutsui S, Vergnolle N, Boven LA, Shariat N, Vodjgani M, Warren KG, Andrade-Gordon P, Hollenberg MD, Power C (2006) Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis. J Exp Med 203(2):425-435 (Pubitemid 43290851)
30. Ooi LL, Zheng Y, Zhou H, Trivedi T, Conigrave AD, Seibel MJ, Dunstan CR (2010) Vitamin D deficiency promotes growth of MCF-7 human breast cancer in a rodent model of osteosclerotic bone metastasis. Bone 47(4):795-803
31. Ossovskaya VS, Bunnett NW (2004) Protease-activated receptors: contribution to physiology and disease. Physiol Rev 84(2):579-621 (Pubitemid 38365493)
32. Pomonis JD, Harrison JE, Mark L, Bristol DR, Valenzano KJ, Walker K (2003) N-(4-Tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetrahydropyrazine- 1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonistwith analgesic properties: II. In vivo characterization in rat models of inflammatory and neuropathic pain. J Pharmacol Exp Ther 306(1):387-393 (Pubitemid 36734396)
33. Ritchie E, Saka M, Mackenzie C, Drummond R, Wheeler-Jones C, Kanke T, Plevin R (2007) Cytokine upregulation of proteinase-activated-receptors 2 and 4 expressionmediated by p38MAP kinase and inhibitory kappa B kinase beta in human endothelial cells. Br J Pharmacol 150(8):1044-1054 (Pubitemid 46625087)
34. Shinoda M, Ogino A, Ozaki N, Urano H, Hironaka K, Yasui M, Sugiura Y (2008) Involvement of TRPV1 in nociceptive behavior in a rat model of cancer pain. J Pain 9(8):687-699
35. Steinhoff M, Vergnolle N, Young SH, Tognetto M, Amadesi S, Ennes HS, Trevisani M, Hollenberg MD, Wallace JL, Caughey GH, Mitchell SE, Williams LM, Geppetti P, Mayer EA, Bunnett NW (2000) Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med 6(2):151-158 (Pubitemid 30082358)
36. Ui H, Andoh T, Lee JB, Nojima H, Kuraishi Y (2006) Potent pruritogenic action of tryptase mediated by PAR-2 receptor and its involvement in anti-pruritic effect of nafamostat mesilate in mice. Eur J Pharmacol 530(1-2):172-178 (Pubitemid 43037138)
37. Vergnolle N, Bunnett NW, Sharkey KA, Brussee V, Compton SJ, Grady EF, Cirino G, Gerard N, Basbaum AI, Andrade-Gordon P, Hollenberg MD, Wallace JL (2001) Proteinase-activated receptor-2 and hyperalgesia: a novel pain pathway. Nat Med 7(7):821-826 (Pubitemid 32691637)
38. Wacnik PW, Kehl LJ, Trempe TM, Ramnaraine ML, Beitz AJ, Wilcox GL (2003) Tumor implantation in mouse humerus evokes movement-related hyperalgesia exceeding that evoked by intramuscular carrageenan. Pain 101(1-2):175-186 (Pubitemid 36044665)
39. Zhang W, Gao J, Zhao T, Wei L, Wu W, Bai Y, Zou D, Li Z (2011) Proteinase-activated receptor 2 mediates thermal hyperalgesia and is upregulated in a rat model of chronic pancreatitis. Pancreas 40(2):300-307
40. Zimmermann M (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16(2):109-110